Covered recipient · General Payments record
KAREN KIM
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2018–2024
$4,683.69
- Reported across 237 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $643.35 | 19 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $278.48 | 11 |
| CVRx Inc. | $169.05 | 1 |
| Amgen Inc. | $102.65 | 4 |
| Lilly USA, LLC | $66.22 | 2 |
| United Therapeutics Corporation | $26.95 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (19)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $24.12 | 03/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104073994 | CMS |
| ABBVIE INC. | $30.72 | 04/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104073996 | CMS |
| ABBVIE INC. | $22.29 | 04/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104073998 | CMS |
| ABBVIE INC. | $23.79 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104074000 | CMS |
| ABBVIE INC. | $23.98 | 07/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104074002 | CMS |
| ABBVIE INC. | $20.65 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104074004 | CMS |
| ABBVIE INC. | $22.31 | 09/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104074006 | CMS |
| ABBVIE INC. | $31.07 | 09/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104074008 | CMS |
| ABBVIE INC. | $34.95 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104074010 | CMS |
| ABBVIE INC. | $11.94 | 11/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104074012 | CMS |
| ABBVIE INC. | $32.66 | 12/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104074014 | CMS |
| Amgen Inc. | $30.97 | 02/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117297506 | CMS |
| Amgen Inc. | $18.45 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111620196 | CMS |
| Amgen Inc. | $29.56 | 06/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111620198 | CMS |
| Amgen Inc. | $23.67 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111620200 | CMS |
| CVRx, Inc. | $169.05 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132815833 | CMS |
| Lilly USA, LLC | $32.40 | 05/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135106753 | CMS |
| Lilly USA, LLC | $33.82 | 09/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135119263 | CMS |
| United Therapeutics Corporation | $26.95 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1149444802 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.